Position in TGTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$116,267,209
+$14,797,965 QoQ
Shares Held
3,499,916
+2.8% QoQ
Ownership
2.29%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,550,967,073 across 528 Biotechnology names. TGTX ranks #34 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in TGTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $116,267,209 | 3,499,916 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $101,469,244 | 3,403,866 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $124,411,573 | 3,443,919 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $125,621,547 | 3,490,457 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $129,431,616 | 3,282,567 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $96,124,499 | 3,193,505 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $74,970,282 | 3,205,228 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $57,041,678 | 3,206,390 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $47,264,223 | 3,107,444 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $52,890,713 | 3,096,646 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $24,526,785 | 2,933,826 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $70,311,830 | 2,830,589 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $40,304,192 | 2,679,800 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $30,595,609 | 2,586,273 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $14,269,798 | 2,410,439 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $9,875,317 | 2,323,604 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $20,812,359 | 2,188,471 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $43,886,903 | 2,309,837 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $76,623,139 | 2,302,378 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $83,657,462 | 2,156,676 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $98,686,222 | 2,047,432 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $92,511,691 | 1,778,387 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $43,454,011 | 1,623,842 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $29,230,655 | 1,500,547 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $13,190,844 | 1,340,533 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||